Incyte Corp (NASDAQ:INCY)

CAPS Rating: 2 out of 5

The Company is a drug discovery and development company focused on developing proprietary small molecule drugs to treat serious unmet medical needs.

Recs

0
Player Avatar pchop123 (80.23) Submitted: 10/15/2012 10:11:03 AM : Outperform Start Price: $17.06 INCY Score: -5.45

green thumb now

Featured Broker Partners


Advertisement